Platinum Investment Management LTD Recursion Pharmaceuticals, Inc. Transaction History

Platinum Investment Management LTD

$2.16 Billion
Q3 2024

A detailed history of Platinum Investment Management LTD transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Platinum Investment Management LTD holds 186,082 shares of RXRX stock, worth $1.19 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

186,082

Previous 395,673 52.97%

Holding current value

$1.19 Million

Previous $2.97 Million 58.68%

% of portfolio

0.06%

Previous 0.12%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$5.92 - $8.6 $1.24 Million - $1.8 Million	-209,591 Reduced 52.97%	186,082 $1.23 Million
Q2 2024 Aug 12, 2024	SELL	$7.35 - $10.05 $10.3 Million - $14.1 Million	-1,404,796 Reduced 78.02%	395,673 $2.97 Million
Q1 2024 May 13, 2024	SELL	$9.13 - $15.52 $4.32 Million - $7.35 Million	-473,495 Reduced 20.82%	1,800,469 $18 Million
Q4 2023 Feb 13, 2024	SELL	$5.09 - $10.79 $311,345 - $660,002	-61,168 Reduced 2.62%	2,273,964 $22.4 Million
Q3 2023 Nov 02, 2023	SELL	$6.59 - $15.86 $2.48 Million - $5.96 Million	-376,016 Reduced 13.87%	2,335,132 $17.9 Million
Q2 2023 Aug 10, 2023	SELL	$4.56 - $9.94 $270,421 - $589,471	-59,303 Reduced 2.14%	2,711,148 $20.3 Million
Q1 2023 May 11, 2023	BUY	$6.42 - $9.64 $385,919 - $579,479	60,112 Added 2.22%	2,770,451 $18.5 Million
Q4 2022 Feb 13, 2023	BUY	$7.16 - $12.7 $3.28 Million - $5.82 Million	458,368 Added 20.35%	2,710,339 $20.9 Million
Q3 2022 Nov 14, 2022	SELL	$7.83 - $13.6 $2.22 Million - $3.86 Million	-283,651 Reduced 11.19%	2,251,971 $24 Million
Q2 2022 Aug 11, 2022	BUY	$5.04 - $9.26 $2.01 Million - $3.69 Million	399,018 Added 18.68%	2,535,622 $20.6 Million
Q1 2022 May 13, 2022	BUY	$6.16 - $18.03 $4.27 Million - $12.5 Million	692,741 Added 47.98%	2,136,604 $15.3 Million
Q4 2021 Feb 11, 2022	BUY	$16.14 - $21.86 $12.6 Million - $17.1 Million	782,160 Added 118.2%	1,443,863 $24.7 Million
Q3 2021 Nov 09, 2021	BUY	$19.03 - $41.33 $3.6 Million - $7.82 Million	189,151 Added 40.03%	661,703 $15.2 Million
Q2 2021 Aug 11, 2021	BUY	$18.0 - $37.42 $8.51 Million - $17.7 Million	472,552 New	472,552 $17.2 Million

Others Institutions Holding RXRX

# of Institutions

289

Shares Held

242M

Call Options Held

1.35M

Put Options Held

2.32M

View Full List

About RECURSION PHARMACEUTICALS, INC.

Ticker RXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 180,480,000
Market Cap $1.16B
Description
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...

More about RXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Platinum Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Platinum Investment Management LTD with notifications on news.

Account

Platinum Investment Management LTD Recursion Pharmaceuticals, Inc. Transaction History